Dr. David I. Rosenthal, MD
- Medicare services, 2024
- 1,314
- Medicare patients, 2024
- 274
- Publications
- 411
- Clinical trials
- 6
- MIPS score, 2024
- 84
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Rosenthal's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David I. Rosenthal is a radiation oncologist in Houston, Texas
Dr. Rosenthal practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Rosenthal's NPI, 1669565719, was assigned on October 2, 2006. Dr. Rosenthal graduated from University of Miami, Miller School of Medicine in 1984. Dr. Rosenthal holds Texas license J2768.
- NPI
- 1669565719NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6709902026
- NPI enumeration date
- October 2, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 68
- Medical school graduation
- 1984
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David I. Rosenthal practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Rosenthal's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. David I. Rosenthal is affiliated with 1 site of care and 1 medical group
Dr. Rosenthal's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. David I. Rosenthal's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenthal practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David I. Rosenthal is one of 401 radiation oncologists in Texas
Radiation oncology is Dr. Rosenthal's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rosenthal is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Rosenthal's licenses on file in 14 states: Texas, Arizona, Georgia, Mississippi, Ohio, Tennessee, Alabama, Florida, Louisiana, North Carolina, Oklahoma, Washington, New Jersey and Pennsylvania.
Specialties and state licenses
- Radiation oncology, TexasPrimary
- Arizona license
- Georgia license
- Mississippi license
- Ohio license
- Tennessee license
- Alabama license
- Florida license
- Louisiana license
- North Carolina license
- Oklahoma license
- Washington license
- New Jersey license
- Pennsylvania license
Clinical focus
Dmand AI lists bone cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Rosenthal treats.
Radiation oncologists near Dr. Rosenthal
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David I. Rosenthal billed Medicare for 1,314 services in 2024
CMS data shows 1,314 Medicare services from Dr. Rosenthal across 14 procedure codes in 2024, for 274 Medicare patients. Medicare paid $66,720 for them.
Dr. Rosenthal's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 7322024: 92126%
- Other services
- 2023: 4822024: 32932%
- Office and hospital visits
- 2023: 582024: 3736%
- Surgery
- 2023: 232024: 2717%
Where Dr. Rosenthal's Medicare services took place, 2024
- In an office34126%
- In a facility97374%
Dr. Rosenthal compared with the Texas median for radiation oncologists, 2024
- Dr. Rosenthal
- Texas median
- Medicare services
- 1,314vs 1,47211% below
- Medicare patients
- 274vs 16467% above
Medians across 370 radiation oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Rosenthal's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rosenthal?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rosenthal and other radiation oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David I. Rosenthal treated 274 Medicare patients in 2024, average age 73
CMS counts 274 Medicare patients who saw Dr. Rosenthal in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rosenthal's median patient age at 70, with 21% women.
Dr. Rosenthal's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Rosenthal's Medicare patients by sex, 2024
- Women6925%
- Men20575%
Chronic conditions among Dr. Rosenthal's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis45%
- Ischemic heart disease36%
- Anxiety31%
- Diabetes30%
- Cancer28%
- Chronic kidney disease27%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rosenthal's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women21%
- Men78%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. David I. Rosenthal scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Rosenthal for performance year 2024, reported as part of a group. Dr. Rosenthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Rosenthal's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David I. Rosenthal has 411 publications on record
Dmand AI links 411 papers to Dr. Rosenthal, published from 2005 to 2025. 2020 was the busiest year, with 31. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Oropharyngeal Neoplasms. Dr. Rosenthal has published most often in Int J Radiat Oncol Biol Phys. Dr. Rosenthal's most frequent co-authors are Clifton David Fuller, MD, Adam S. Garden, MD and William H. Morrison, MD.
Dr. Rosenthal's papers by year, 2016 to 2025
Topics Dr. Rosenthal writes about most
- Head and Neck Neoplasms
- Carcinoma, Squamous Cell
- Oropharyngeal Neoplasms
- Radiotherapy Dosage
- Radiotherapy, Intensity-Modulated
- Radiation Injuries
- Antineoplastic Combined Chemotherapy Protocols
- Chemoradiotherapy
Dr. Rosenthal's most frequent co-authors
- Clifton David Fuller, MD129 shared papers
- Adam S. Garden, MD121 shared papers
- William H. Morrison, MD95 shared papers
Recent publications by Dr. Rosenthal
See who Dr. Rosenthal researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rosenthal works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David I. Rosenthal has worked on 6 clinical trials
Dmand AI links Dr. Rosenthal to 6 clinical trials, 2 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Mucositis, cyclopia sequence and Heartburn. M.D. Anderson Cancer Center sponsors the most, 3.
Clinical trials with Dr. Rosenthal by phase
- NonePhase 1: no trials
- 2Phase 1/2: 2 trials
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Rosenthal's trials
- Mucositis
- cyclopia sequence
- Heartburn
- Oropharyngeal Neoplasms
- Stomach Neoplasms
Investigators on the most trials with Dr. Rosenthal
Recent clinical trials with Dr. Rosenthal
Symptom Burden in Head and Neck Cancer (opens in a new tab)
Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy (opens in a new tab)
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David I. Rosenthal received $63,865 in industry payments from 2016 to 2023
CMS Open Payments shows 67 general payments to Dr. Rosenthal from 3 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 86% of the total. Merck Sharp & Dohme Corporation paid the most, $60,974.
General payments to Dr. Rosenthal by program year, 2016 to 2023
General payments to Dr. Rosenthal by kind, 2016 to 2023
- Consulting fees$54,67086%
- Travel and lodging$7,58312%
- Food and beverage$1,6123%
Companies that paid Dr. Rosenthal the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. David I. Rosenthal graduated from University of Miami, Miller School of Medicine
Dr. Rosenthal graduated from University of Miami, Miller School of Medicine in 1984.
- Medical school
- Board certified in radiation oncology
Source: Dmand AI Professional Profile Data
Dr. David I. Rosenthal accepts plans from 16 insurance carriers
Dr. Rosenthal is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Alliant Health Plans
- HCSC
- Aspirus Health Plan
- +8 more carriersWith a free account
Plan types Dr. Rosenthal accepts, by number of carriers
- HMO10
- PPO9
- POS7
- EPO4
- Medicare4
Source: Dmand AI Insurance Network Data
Sources for Dr. David I. Rosenthal's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David I. Rosenthal
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David I. Rosenthal's NPI number?
Dr. David I. Rosenthal's NPI number is 1669565719. It was assigned on October 2, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David I. Rosenthal?
Dr. David I. Rosenthal is a radiation oncologist in Houston, Texas. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. David I. Rosenthal practice?
Dr. Rosenthal practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Rosenthal's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. David I. Rosenthal's medical license number?
Dr. Rosenthal holds Texas license J2768, one of the licenses on file in 14 states.
Which states has Dr. David I. Rosenthal been licensed in?
Dmand AI has state licenses on file for Dr. Rosenthal in Texas (1992 to 2026), Arizona (2023 to 2027), Georgia (2023 to 2026), Mississippi (2023 to 2026), Ohio (1986 to 2026), Tennessee (2023 to 2026), Alabama (2023 to 2025), Florida (1988 to 2025), Louisiana (2023 to 2025), North Carolina (1988 to 2025), Oklahoma (2020 to 2025), Washington (2023 to 2025), New Jersey (1999 to 2007) and Pennsylvania (1996 to 2006).
Which hospitals is Dr. David I. Rosenthal affiliated with?
Dr. Rosenthal practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. David I. Rosenthal part of?
Dr. Rosenthal is linked to Physicians Referral Service.
Does Dr. David I. Rosenthal accept Medicare?
Yes. CMS data shows Dr. Rosenthal billed Medicare for 1,314 services in 2024, and Dr. Rosenthal accepts Medicare assignment.
What is Dr. David I. Rosenthal's MIPS score?
Dr. Rosenthal's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. David I. Rosenthal see?
CMS counts 274 Medicare patients who saw Dr. Rosenthal in 2024, with an average age of 73.
Show 8 more questionsShow fewer questions
Is Dr. David I. Rosenthal board certified?
Yes. Dr. Rosenthal is board certified in radiation oncology by the American Board of Radiology.
What services does Dr. David I. Rosenthal bill to Medicare?
In 2024, Dr. Rosenthal's most billed Medicare services were radiation oncology (77014), medicare service (G6002) and radiation oncology (77427).
Where did Dr. David I. Rosenthal go to medical school?
Dr. Rosenthal graduated from University of Miami, Miller School of Medicine in 1984.
Has Dr. David I. Rosenthal received payments from drug or device companies?
CMS Open Payments shows $63,865 in general payments to Dr. Rosenthal from 3 companies from 2016 to 2023. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. David I. Rosenthal been practicing?
Dr. Rosenthal graduated from medical school in 1984, 42 years ago.
Does Dr. David I. Rosenthal do research?
Dmand AI links 411 publications to Dr. Rosenthal, published from 2005 to 2025. Dr. Rosenthal has worked on 6 clinical trials.
Who does Dr. David I. Rosenthal publish with?
Dr. Rosenthal's most frequent co-authors are Clifton David Fuller, MD (129 shared papers), Adam S. Garden, MD (121 shared papers) and William H. Morrison, MD (95 shared papers).
What insurance does Dr. David I. Rosenthal accept?
Dr. Rosenthal is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to radiation oncology practices?
See radiation oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card